Crossmark

Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo

Crossref DOI link: https://doi.org/10.1038/s41591-018-0165-9

Published Online: 2018-09-24

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gammage, Payam A. https://orcid.org/0000-0003-1968-1726
Viscomi, Carlo https://orcid.org/0000-0001-6050-0566
Simard, Marie-Lune

Costa, Ana S. H.

Gaude, Edoardo

Powell, Christopher A.

Van Haute, Lindsey

McCann, Beverly J.

Rebelo-Guiomar, Pedro

Cerutti, Raffaele

Zhang, Lei

Rebar, Edward J.

Zeviani, Massimo

Frezza, Christian https://orcid.org/0000-0002-3293-7397
Stewart, James B. https://orcid.org/0000-0002-2902-4968
Minczuk, Michal https://orcid.org/0000-0001-8242-1420
License Information

Text and Data Mining valid from 2018-09-24
More Information

Article History

Received: 15 February 2018

Accepted: 26 July 2018

First Online: 24 September 2018

Competing interests

: E.J.R. and L.Z. are full-time employees of Sangamo Therapeutics.